HWAM
ZVRA icon

Hennion & Walsh Asset Management’s Zevra Therapeutics ZVRA Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.5M Buy
383,706
+206,543
+117% +$2.3M 0.16% 167
2026
Q1 		$1.65M Buy
177,163
+37,572
+27% +$339K 0.06% 393
2025
Q4 		$1.25M Buy
+139,591
New +$1.32M 0.04% 468

Other funds holding ZVRA

RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
IA
IFG Advisors St. Louis, Missouri $725M AUM 27.52% 1-Year Est. Return
ES
Element Squared Minneapolis, Minnesota $201M AUM 27.42% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
QWM
Quaker Wealth Management Moorestown, New Jersey $344M AUM 15.21% 1-Year Est. Return

Hennion & Walsh Asset Management's ZVRA Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Zevra Therapeutics (ZVRA) stake by 117% in Q2 2026, buying an estimated $2.3M and bringing the position to 383,706 shares worth $5.5M. The position accounts for 0.16% of the portfolio, ranked #167.

Hennion & Walsh Asset Management first reported a position in ZVRA in Q4 2025 and has held it in 3 quarters since. 31 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Hennion & Walsh Asset Management held 383,706 shares of Zevra Therapeutics worth $5.5M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 206,543 Zevra Therapeutics shares in Q2 2026, an estimated $2.3M.
  • Zevra Therapeutics made up 0.16% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #167 holding.
  • Hennion & Walsh Asset Management first reported a position in Zevra Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 31 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.